USD 2.44 billion Growth in Travel Vaccines Market Size with 42% of the contribution from North America - Technavio

NEW YORK, Aug. 22, 2022 /PRNewswire/ -- The latest market analysis report titled Travel Vaccines Market by Disease Type and Geography - Forecast and Analysis 2022-2026 has been recently added to Technavio's catalog. The report analysts have categorized the global travel vaccines market as a part of the global pharmaceuticals market. Our report provides extensive information on the value chain analysis for the travel vaccines market, which vendors can leverage to gain a competitive advantage during the forecast period. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period. One of the key factors driving the global travel vaccines market growth is the increase in global travel and migration. In addition, changes in the demographic profile of travelers globally are one of the key travel vaccines market trends that are expected to impact the industry positively in the forecast period. However, the absence of coverage for travel vaccines in many health plans is expected to limit the market's growth during the forecast period.

For market scope, value chain analysis, and key market dynamics, Read a FREE Sample

Travel Vaccines Market Segmentation Highlights

• Regional Opportunities
• North America: 42% of the market's growth will originate from North America during the forecast period. The US is the key market for travel vaccines in North America. Market growth in this region will be faster than the growth of the market in the Rest of World (ROW). Increasing access to vaccines against diseases and a growing number of initiatives to generate awareness about immunization programs will fuel the travel vaccines market growth in North America over the forecast period.
• Europe
• Asia
• Rest Of World (ROW)
• Revenue-generating Disease Type Segment
• Influenza: The travel vaccines market share growth in the influenza segment will be significant during the forecast period. The growing demand for influenza vaccines by the end-user facilities coupled with the rise in traveling rate will drive the segment growth in the coming years. There are multiple vendors operating in the global travel vaccines market for influenza, some of whom are the top and most well-established players in the vaccines market, such as GlaxoSmithKline Plc, Sanofi SA (Sanofi), and CSL Ltd. (CSL), which contribute significantly to the global travel vaccines market for influenza. 
• Diptheria
• Hepatitis
• Others

For more segment-based insights and regional opportunities, Request for Sample Report

• The travel vaccines market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market. The travel vaccines market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
• Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE are some of the major market participants.
• To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. 
• Vendors are offering a wide range of offerings to gain a competitive edge in the market. For instance, CSL Ltd. offers the broadest influenza vaccine and a wide range of vaccines and specialty medicines that meet unique, local public health needs. Bharat Biotech Ltd. offers travel vaccines such as BioHib, a lyophilized vaccine that is used for development based on an Indian strain.
• Backed with competitive intelligence and benchmarking, our research reports on the travel vaccines market are designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

More vendor offerings and their strategic initiatives are available in this PDF Sample Report

Travel Vaccines Market Scope

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. Our travel vaccines market report covers the following areas:

• Travel Vaccines Market size
• Travel Vaccines Market trends
• Travel Vaccines Market industry analysis

Travel Vaccines Market Highlights

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will assist travel vaccines market growth during the next five years
• Estimation of the travel vaccines market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the travel vaccines market
• Analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of travel vaccines market vendors

Related Reports:

Vaccines Market by Type and Geography - Forecast and Analysis 2022-2026

Human Combination Vaccines Market by Type and Geography - Forecast and Analysis 2021-2025

Therapeutic Vaccines Market by Type and Geography - Forecast and Analysis 2020-2024

Foot and Mouth Disease Vaccines Market by Product and Geography - Forecast and Analysis 2021-2025

Table Of Contents :

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

• 5.1 Market segments
• Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)

• 5.2 Comparison by Disease Type
• Exhibit 26: Chart on Comparison by Disease Type
• Exhibit 27: Data Table on Comparison by Disease Type

• 5.3 Influenza - Market size and forecast 2021-2026
• Exhibit 28: Chart on Influenza - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Influenza - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Influenza - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Influenza - Year-over-year growth 2021-2026 (%)

• 5.4 Diptheria - Market size and forecast 2021-2026
• Exhibit 32: Chart on Diptheria - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Diptheria - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Diptheria - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Diptheria - Year-over-year growth 2021-2026 (%)

• 5.5 Hepatitis - Market size and forecast 2021-2026
• Exhibit 36: Chart on Hepatitis - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Hepatitis - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Hepatitis - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Hepatitis - Year-over-year growth 2021-2026 (%)

• 5.6 Others - Market size and forecast 2021-2026
• Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.7 Market opportunity by Disease Type
• Exhibit 44: Market opportunity by Disease Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 46: Chart on Market share by geography 2021-2026 (%)
• Exhibit 47: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 48: Chart on Geographic comparison
• Exhibit 49: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.10 Japan - Market size and forecast 2021-2026
• Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.11 China - Market size and forecast 2021-2026
• Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 86: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 87: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 88: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 89: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 90: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 91: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 92: Matrix on vendor position and classification

• 10.3 Bharat Biotech Ltd.
• Exhibit 93: Bharat Biotech Ltd. - Overview
• Exhibit 94: Bharat Biotech Ltd. - Product / Service
• Exhibit 95: Bharat Biotech Ltd. - Key news
• Exhibit 96: Bharat Biotech Ltd. - Key offerings

• 10.4 CSL Ltd.
• Exhibit 97: CSL Ltd. - Overview
• Exhibit 98: CSL Ltd. - Business segments
• Exhibit 99: CSL Ltd. - Key news
• Exhibit 100: CSL Ltd. - Key offerings
• Exhibit 101: CSL Ltd. - Segment focus

• 10.5 GlaxoSmithKline Plc
• Exhibit 102: GlaxoSmithKline Plc - Overview
• Exhibit 103: GlaxoSmithKline Plc - Business segments
• Exhibit 104: GlaxoSmithKline Plc - Key news
• Exhibit 105: GlaxoSmithKline Plc - Key offerings
• Exhibit 106: GlaxoSmithKline Plc - Segment focus

• 10.6 Merck and Co. Inc.
• Exhibit 107: Merck and Co. Inc. - Overview
• Exhibit 108: Merck and Co. Inc. - Business segments
• Exhibit 109: Merck and Co. Inc. - Key news
• Exhibit 110: Merck and Co. Inc. - Key offerings
• Exhibit 111: Merck and Co. Inc. - Segment focus

• 10.7 Mitsubishi Chemical Holdings Corp.
• Exhibit 112: Mitsubishi Chemical Holdings Corp. - Overview
• Exhibit 113: Mitsubishi Chemical Holdings Corp. - Business segments
• Exhibit 114: Mitsubishi Chemical Holdings Corp. - Key offerings
• Exhibit 115: Mitsubishi Chemical Holdings Corp. - Segment focus

• 10.8 Pfizer Inc.
• Exhibit 116: Pfizer Inc. - Overview
• Exhibit 117: Pfizer Inc. - Product / Service
• Exhibit 118: Pfizer Inc. - Key news
• Exhibit 119: Pfizer Inc. - Key offerings

• 10.9 Sanofi
• Exhibit 120: Sanofi - Overview
• Exhibit 121: Sanofi - Business segments
• Exhibit 122: Sanofi - Key news
• Exhibit 123: Sanofi - Key offerings
• Exhibit 124: Sanofi - Segment focus

• 10.10 Serum Institute of India Pvt. Ltd.
• Exhibit 125: Serum Institute of India Pvt. Ltd. - Overview
• Exhibit 126: Serum Institute of India Pvt. Ltd. - Product / Service
• Exhibit 127: Serum Institute of India Pvt. Ltd. - Key offerings

• 10.11 SK Chemicals Co. Ltd.
• Exhibit 128: SK Chemicals Co. Ltd. - Overview
• Exhibit 129: SK Chemicals Co. Ltd. - Business segments
• Exhibit 130: SK Chemicals Co. Ltd. - Key offerings
• Exhibit 131: SK Chemicals Co. Ltd. - Segment focus

• 10.12 Takeda Pharmaceutical Co. Ltd.
• Exhibit 132: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 133: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 134: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 135: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 136: Inclusions checklist
• Exhibit 137: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 138: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 139: Research methodology
• Exhibit 140: Validation techniques employed for market sizing
• Exhibit 141: Information sources

• 11.5 List of abbreviations
• Exhibit 142: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED